Literature DB >> 12165546

Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells.

Eisei Kondo1, Max S Topp, Hans-Peter Kiem, Yuichi Obata, Yasuo Morishima, Kiyotaka Kuzushima, Mitsune Tanimoto, Mine Harada, Toshitada Takahashi, Yoshiki Akatsuka.   

Abstract

The development of rapid, efficient, and safe methods for generating Ag-specific T cells is necessary for the clinical application of adoptive immunotherapy. We show that B cells stimulated with CD40 ligand and IL-4 (CD40-B cells) can be efficiently transduced with retroviral vectors encoding a model Ag, CMV tegument protein pp65 gene, and maintain high levels of costimulatory molecules after gene transfer. CTL lines specific for pp65 were readily generated in all four healthy CMV-seropositive donors by stimulating autologous CD8(+) T cells with these transduced CD40-B cells, both of which were derived from 10 ml peripheral blood. ELISPOT assays revealed that the CTL lines used multiple HLA alleles as restricting elements. Thus, CD40-B cells transduced retrovirally with Ag-encoding cDNA can be potent APC and facilitate to generate Ag-specific CTL in vitro.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165546     DOI: 10.4049/jimmunol.169.4.2164

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  HLA-F is a surface marker on activated lymphocytes.

Authors:  Ni Lee; Akiko Ishitani; Daniel E Geraghty
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

2.  Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.

Authors:  G A Van den Bosch; P Ponsaerts; G Nijs; M Lenjou; G Vanham; D R Van Bockstaele; Z N Berneman; V F I Van Tendeloo
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

3.  Murine model of CD40-activation of B cells.

Authors:  Tanja M Liebig; Anne Fiedler; Nela Klein-Gonzalez; Alexander Shimabukuro-Vornhagen; Michael von Bergwelt-Baildon
Journal:  J Vis Exp       Date:  2010-03-05       Impact factor: 1.355

4.  CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants.

Authors:  Michael von Bergwelt-Baildon; Alexander Shimabukuro-Vornhagen; Alexey Popov; Nela Klein-Gonzalez; Francesca Fiore; Svenja Debey; Andreas Draube; Britta Maecker; Isaura Menezes; Lee M Nadler; Joachim L Schultze
Journal:  Blood       Date:  2005-12-15       Impact factor: 22.113

5.  Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression.

Authors:  Qiao Li; Xiangming Lao; Qin Pan; Ning Ning; Ji Yet; Yingxin Xu; Shengping Li; Alfred E Chang
Journal:  Clin Cancer Res       Date:  2011-06-20       Impact factor: 12.531

6.  Impaired tumor antigen processing by immunoproteasome-expressing CD40-activated B cells and dendritic cells.

Authors:  Karen S Anderson; Wanyong Zeng; Tetsuro Sasada; Jaewon Choi; Angelika B Riemer; Mei Su; Donna Drakoulakos; Yoon-Joong Kang; Vladimir Brusic; Catherine Wu; Ellis L Reinherz
Journal:  Cancer Immunol Immunother       Date:  2011-03-13       Impact factor: 6.968

7.  An effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigens.

Authors:  Bei Wang; Jin He; Chen Liu; Lung-Ji Chang
Journal:  Vaccine       Date:  2006-02-28       Impact factor: 3.641

Review 8.  CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential.

Authors:  E Kondo; L Gryschok; N Klein-Gonzalez; S Rademacher; M R Weihrauch; T Liebig; A Shimabukuro-Vornhagen; M Kochanek; A Draube; M S von Bergwelt-Baildon
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

9.  CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides.

Authors:  Tahamtan Ahmadi; Amanda Flies; Yvonne Efebera; David H Sherr
Journal:  Immunology       Date:  2007-12-07       Impact factor: 7.397

10.  Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen.

Authors:  S Guo; J Xu; W Denning; Z Hel
Journal:  Gene Ther       Date:  2009-07-30       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.